Dusseldorf - Delayed Quote EUR
Ryvu Therapeutics SA (9Y4.DU)
7.31
-0.24
(-3.18%)
As of April 29 at 7:31:25 PM GMT+2. Market Open.
Loading Chart for 9Y4.DU
- Previous Close
7.55 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 12.70 - Volume
0 - Avg. Volume
2 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 9Y4.DU
View MorePerformance Overview: 9Y4.DU
Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
9Y4.DU
17.40%
MSCI WORLD (^990100-USD-STRD)
1.88%
1-Year Return
9Y4.DU
34.96%
MSCI WORLD (^990100-USD-STRD)
0.00%
3-Year Return
9Y4.DU
44.87%
MSCI WORLD (^990100-USD-STRD)
27.52%
5-Year Return
9Y4.DU
44.87%
MSCI WORLD (^990100-USD-STRD)
80.34%
Compare To: 9Y4.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 9Y4.DU
View MoreValuation Measures
As of 4/29/2025
Market Cap
178.32M
Enterprise Value
143.23M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.26
Price/Book (mrq)
5.02
Enterprise Value/Revenue
7.85
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--